CLW

Clearwater Paper Corp. 10-Q Summary: Q3 2025

Business Context and Reporting Period

This report covers the quarterly period ended September 30, 2025. Clearwater Paper Corporation is a manufacturer of bleached paperboard focused on independent converters in North America. The company operates as a single segment following the sale of its tissue (consumer products) operations in November 2024, which are now reported as discontinued operations. The company is a large accelerated filer with 16,038,337 shares of common stock outstanding as of October 27, 2025.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue: Q3 net sales increased 1% year-over-year due to higher volume offset by price decreases. Nine-month sales rose 17%, driven by the inclusion of the Augusta, Georgia facility acquired in May 2024.
• Profitability: The company reported a net loss of $53.3M for Q3 2025 compared to a net income of $5.8M in Q3 2024. This deterioration was primarily driven by a $48.0 million non-cash goodwill impairment charge recorded in Q3 2025 due to a sustained decline in market capitalization and paperboard market softness.
• Costs: Cost of sales increased 5% in Q3 due to the timing of planned maintenance outages. Gross margin percentage declined from 8% in Q3 2024 to 5% in Q3 2025.
• Cash Flow: Operating cash flow for the nine months ended September 30, 2025, dropped significantly to $7.3M from $96.5M in the prior year, largely due to the divestiture of the tissue business (which contributed to 2024 cash flow) and a $57M payment of 2024 income tax liabilities.
• Debt: Total debt increased to $336.1M from $282.2M at year-end 2024, reflecting borrowings under the ABL Credit Agreement to fund operations and capital expenditures.

Guidance, Outlook, and Risks

• Outlook: Management expects Q4 2025 sales volumes to decline due to seasonality. Energy costs are expected to rise seasonally, while maintenance outage expenses are expected to decrease compared to Q3. A union agreement at the Lewiston, Idaho facility expired in Q3; retroactive wage adjustments are expected upon ratification of a new agreement.
• Tariffs and Legislation: The company is evaluating the impact of new U.S. tariffs (10% baseline plus country-specific rates) but does not currently expect a significant impact on 2025 results. The "One Big Beautiful Bill Act" (OBBBA) was signed into law but had no material impact on Q3 financials.
• Augusta Acquisition: The company has filed a representation-and-warranty insurance claim with carriers regarding the Augusta facility acquisition, seeking up to $105 million. No recovery has been recognized as of September 30, 2025.
• Legal Proceedings: Clearwater is a defendant in an environmental lawsuit in Georgia regarding PFAS contamination in the water supply near the Augusta facility. The company intends to vigorously defend the claim.
• Restructuring: The company is executing a cost-reduction plan following the tissue divestiture, with expected severance costs of $5M to $7M by year-end 2025.

Investor Verification Checklist

• Goodwill Impairment: Verify the assumptions used in the fair value assessment that led to the full $48.0M impairment of goodwill.
• Insurance Claim Status: Monitor the status of the $105M representation-and-warranty insurance claim related to the Augusta acquisition.
• Liquidity Position: Assess the impact of the $57M tax payment and reduced operating cash flow on the company's ability to service its $336M debt load and meet covenants.
• Union Negotiations: Track the outcome of the Lewiston, Idaho union negotiations and the potential financial impact of retroactive wage payments.
• PFAS Litigation: Review developments in the Georgia environmental lawsuit regarding potential liabilities at the Augusta facility.